TSO3 Inc. Engages in New U.S. Regulatory Process
Canadian company TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the company is having productive discussions with U.S. regulators; the company is actively engaged in the changing U.S. regulatory process intended to lead to the refiling for 510(k) clearance on its new-generation sterilizer.
"Based on recent disclosure from the U.S. Food and Drug Administration (FDA), we can see a changing emphasis on what is expected for devices to clear the 510(k) process," says Charles O. Hancock, RAC, regulatory consultant for TSO3. "The agency wants to make the process more predictable. This means more discussions and guidance upfront before filings, which is intended to lead to a more predictable and timely review."
R.M. Rumble, TSO3's president and CEO, notes, "We understand the nature of the regulators' process and are confident we can respond to their need for scientifically valid explanations and justifications in a timely manner. This new process we are currently engaged in with the U.S. regulators involves more discussions before we are ready to file. We see this positively as it will make the outcome of our filing more predictable. We are very confident in our ability to respond with a compliant submission and will disclose when we file our new application."
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
